Silvia Steiner

Having joined Osborne Clarke in 2007, there’s little doubt about Silvia’s specialism – she has devoted her entire career to life sciences and healthcare.
Today, Silvia applies that wealth of knowledge to her role. In doing so, she has worked with a wealth of high-profile clients, both nationally and internationally, including a long-term relationship with one of the world leaders in plasma-based products.
An expert in commercial law, Silvia is often called on for her advisory skills in commercial transactions, as well as regulatory issues around clinical trials, R&D activities and market access. In each instance, her approach is collaborative – in a sector which is evolving rapidly, Silvia works in close co-ordination with every client, keeping pace with change as it happens.
During her career Silvia has also gained considerable experience and skill in Corporate Compliance, with a particular focus in anticorruption related matters.
The definition of "foreign official” and clarification of criminal violations of accounting provisions are among the updates in a new...
The Resource Guide to the U.S. Foreign Corrupt Practices Act (the "Resource Guide") was originally released in November 2012. The...
The European telemedicine industry is on the rise as a result of recent legalisation of activities such as remote treatment...
The European Parliament and the Council of the European Union approve the Directive for the harmonisation of the protection of...
The European Parliament approves, by a large majority, the Commission's proposal of EU Directive to strengthen whistleblowers protection at Community...
With less than four months until the UK officially leaves the EU, amid confidence votes and delayed votes in the...
MedTech Europe establishes a 2020 roadmap for member companies and national associations to adopt the standards established in its code...